Structures by: Aravindhan S.
Total: 44
<i>N</i>-<i>tert</i>-Butyl-2-(4-methoxyphenyl)-5-methylimidazo[1,2-<i>a</i>]pyridin-3-amine
C19H23N3O
Acta Crystallographica Section E (2018) 74, 12 1913-1918
a=9.2357(7)Å b=15.6388(12)Å c=11.9840(10)Å
α=90° β=93.998(3)° γ=90°
<i>N</i>-<i>tert</i>-Butyl-2-[4-(dimethylamino)phenyl]imidazo[1,2-<i>a</i>]pyridin-3-amine
C19H24N4
Acta Crystallographica Section E (2018) 74, 12 1913-1918
a=34.9185(14)Å b=8.4656(5)Å c=11.8361(6)Å
α=90° β=91.061(5)° γ=90°
4-Bromo-2-(diethoxymethyl)phenyl benzoate
C18H19BrO4
Acta crystallographica. Section E, Structure reports online (2013) 69, Pt 4 o553
a=8.2662(8)Å b=9.6378(10)Å c=11.6224(13)Å
α=99.927(5)° β=93.700(5)° γ=101.178(5)°
1-Benzenesulfonyl-2-methyl-3-(4-nitrobenzoyl)-2,3-dihydro-1<i>H</i>-indole
C22H16N2O5S
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1555-1559
a=8.1358(2)Å b=23.8364(7)Å c=10.5983(3)Å
α=90° β=110.2100(10)° γ=90°
1-Benzenesulfonyl-2-methyl-3-[(thiophen-2-yl)carbonyl]-2,3-dihydro-1<i>H</i>-indole
C20H15NO3S2
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 10 1555-1559
a=8.9300(2)Å b=10.8141(3)Å c=18.6398(5)Å
α=90° β=90° γ=90°
2,4-Bis(pyridine-2-carbonyl)-1-(2-pyridyl)-3,5-bis(4-tolyl)cyclohex-1-ol
C37H33N3O3
Acta Crystallographica Section E (2004) 60, 12 o2353-o2355
a=8.534(7)Å b=34.067(10)Å c=10.458(5)Å
α=90.00° β=98.91(5)° γ=90.00°
Methyl 4-oxo-r-2,c-6-diphenylpiperidine-3-carboxylate
C19H19NO3
Acta Crystallographica Section E (2004) 60, 11 o2105-o2106
a=9.7563(13)Å b=7.7100(10)Å c=22.810(3)Å
α=90.00° β=102.348(4)° γ=90.00°
1,2-Bis(2-chlorophenyl)-1,2-bis(3,4-dimethylphenyl)ethane-1,2-diol
C30H28Cl2O2
Acta Crystallographica Section E (2005) 61, 4 o886-o888
a=7.667(2)Å b=22.862(6)Å c=14.654(4)Å
α=90.00° β=104.478(4)° γ=90.00°
2-Hydroxyethyl 4-hydroxybenzoate
C9H10O4
Acta Crystallographica Section E (2011) 67, 2 o442
a=4.4235(10)Å b=5.6850(17)Å c=8.7050(17)Å
α=80.819(13)° β=79.943(14)° γ=81.804(14)°
(<i>Z</i>)-4-{1-[(2-Hydroxyethyl)amino]ethylidene}-3-methyl-1-phenyl-1<i>H</i>-\ pyrazol-5(4<i>H</i>)-one
C14H17N3O2
Acta Crystallographica Section E (2011) 67, 2 o444
a=22.4703(13)Å b=7.0902(4)Å c=18.0565(11)Å
α=90.00° β=110.926(7)° γ=90.00°
1-Acetyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C21H23NO2
Acta Crystallographica Section E (2009) 65, 8 o1974
a=7.5622(4)Å b=10.6369(5)Å c=11.1497(7)Å
α=90.00° β=100.373(3)° γ=90.00°
1-Benzoyl-<i>c</i>-3,<i>t</i>-3-dimethyl-<i>r</i>-2,<i>c</i>-6-diphenylpiperidin-4-one
C26H25NO2
Acta Crystallographica Section E (2009) 65, 8 o1975
a=10.8540(9)Å b=17.8050(17)Å c=10.8853(10)Å
α=90.00° β=94.987(3)° γ=90.00°
Ethyl 2-benzyl-3-[3-(4-chlorophenyl)-1-phenyl-1<i>H</i>-pyrazol-4-yl]-4,6- dioxo-5-phenyloctahydropyrrolo[3,4-<i>c</i>]pyrrole-1-carboxylate
C37H31ClN4O4
Acta Crystallographica Section E (2012) 68, 2 o552
a=12.8293(8)Å b=13.3467(8)Å c=22.0754(11)Å
α=83.897(4)° β=81.585(5)° γ=62.213(6)°
(1'<i>S</i>,12'<i>R</i>,13'<i>S</i>,17'<i>S</i>)-15',15'-Dimethyl-1,2-dihydro-11',14',16',18'-tetraoxa-7'-azaspiro[indole-3,8'-pentacyclo[10.6.0.0^2,9^.0^3,7^.0^13,17^]octadecane]-2,10'-dione
C22H24N2O6
Acta Crystallographica Section E (2013) 69, 4 o466
a=9.2737(5)Å b=11.6543(8)Å c=18.8489(14)Å
α=90.00° β=90.00° γ=90.00°
(2<i>E</i>,4<i>E</i>)-Ethyl 5-(2,4-dichlorophenylsulfonyl)penta-2,4-dienoate
C13H12Cl2O4S
Acta Crystallographica Section E (2013) 69, 9 o1387
a=5.773(5)Å b=9.939(5)Å c=13.268(5)Å
α=90.00° β=95.876(5)° γ=90.00°
Diethyl [benzylamino(1,3-diphenyl-1<i>H</i>-pyrazol-4- yl)methyl]phosphonate
C27H30N3O3P
Acta Crystallographica Section E (2011) 67, 9 o2376
a=10.9534(4)Å b=9.3777(3)Å c=25.0690(8)Å
α=90.00° β=101.233(2)° γ=90.00°
Diethyl [(2-bromoanilino)(1,3-diphenyl-1<i>H</i>-pyrazol-4-yl)methyl]phosphonate
C26H27BrN3O3P
Acta Crystallographica Section E (2012) 68, 5 o1554
a=11.2553(6)Å b=23.9104(15)Å c=9.4741(5)Å
α=90.00° β=91.229(3)° γ=90.00°
(<i>Z</i>)-3-(2-Chlorobenzyl)-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H12ClNOS
Acta Crystallographica Section E (2012) 68, 7 o2283
a=8.4958(3)Å b=8.7197(3)Å c=10.0520(3)Å
α=101.9300(10)° β=95.179(2)° γ=90.314(2)°
(2<i>E</i>,2'<i>E</i>)-Dimethyl 2,2'-[(phenylazanediyl)bis(methylene)]bis(3-phenylacrylate)
C28H27NO4
Acta Crystallographica Section E (2012) 68, 7 o2265
a=9.9099(2)Å b=11.7327(2)Å c=12.4079(4)Å
α=101.131(2)° β=106.039(2)° γ=114.8170(10)°
5,5'-Methylenebis(2-isopropoxybenzaldehyde)
C21H24O4
Acta Crystallographica Section E (2012) 68, 7 o2199
a=26.337(9)Å b=28.349(10)Å c=4.990(2)Å
α=90.00° β=90.00° γ=90.00°
Methyl 9-hydroxy-15-methyl-2-oxo-11-(pyren-1-yl)-10-oxa-15-azatetracyclo[7.6.0.0^1,12^.0^3,8^]pentadeca-3(8),4,6-triene-12-carboxylate
C32H25NO5
Acta Crystallographica Section E (2013) 69, 10 o1569
a=31.6964(6)Å b=11.0325(2)Å c=14.1965(3)Å
α=90.00° β=96.5030(10)° γ=90.00°
Methyl 8-bromo-3-[1-(4-methoxyphenyl)-4-oxo-3-phenylazetidin-2-yl]-1-methyl-1,2,3,3a,4,9b-hexahydrochromeno[4,3-<i>b</i>]pyrrole-3a-carboxylate
C30H29BrN2O5
Acta Crystallographica Section E (2013) 69, 10 o1570
a=10.904(5)Å b=10.765(5)Å c=11.405(5)Å
α=90.000° β=91.681(5)° γ=90.000°
14-Ethoxy-4,6-dimethyl-9-phenyl-8,12-dioxa-4,6- diazatetracyclo[8.8.0.0^2,7^.0^13,18^]octadeca-2(7),13,15,17-tetraene- 3,5,11-trione
C23H20N2O6
Acta Crystallographica Section E (2013) 69, 1 o80
a=16.8362(9)Å b=8.1692(4)Å c=14.4400(8)Å
α=90.00° β=98.000(3)° γ=90.00°
(<i>E</i>)-1,3-Dimethyl-2,6-diphenylpiperidin-4-one <i>O</i>-(phenoxycarbonyl)oxime
C26H26N2O3
Acta Crystallographica Section E (2014) 70, 6 o713
a=16.2004(12)Å b=11.9587(10)Å c=11.3601(7)Å
α=90.00° β=102.547(2)° γ=90.00°
3-[(<i>Z</i>)-Benzylidene]-2,3-dihydro-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2011) 67, 11 o3061
a=10.7711(9)Å b=7.8736(7)Å c=31.610(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl (<i>E</i>)-2-({2-[(<i>E</i>)-(hydroxyimino)methyl]phenoxy}methyl)- 3-phenylacrylate
C18H17NO4
Acta Crystallographica Section E (2012) 68, 3 o608
a=9.6463(4)Å b=7.7062(3)Å c=22.4675(9)Å
α=90.00° β=100.337(2)° γ=90.00°
(<i>E</i>)-2-({2-[(<i>E</i>)-(Hydroxyimino)methyl]phenoxy}methyl)- 3-<i>p</i>-tolylacrylonitrile
C18H16N2O2
Acta Crystallographica Section E (2012) 68, 3 o570
a=8.4851(2)Å b=9.3900(3)Å c=10.0779(3)Å
α=100.208(2)° β=90.7250(10)° γ=105.2060(10)°
(2<i>E</i>,4<i>E</i>)-Ethyl 5-(phenylsulfonyl)penta-2,4-dienoate
C13H14O4S
Acta Crystallographica Section E (2012) 68, 4 o1093
a=6.2525(3)Å b=7.8889(4)Å c=14.5049(7)Å
α=82.828(3)° β=87.261(2)° γ=72.426(2)°
(<i>Z</i>)-3-Benzyl-1,5-benzothiazepin-4(5<i>H</i>)-one
C16H13NOS
Acta Crystallographica Section E (2012) 68, 8 o2329
a=9.3409(6)Å b=11.7876(7)Å c=11.8310(6)Å
α=90.00° β=94.727(3)° γ=90.00°
1-(2-Carboxyethyl)-5-ethyl-2-methylpyridinium chloride
C11H16NO2,Cl
Acta Crystallographica Section E (2012) 68, 10 o2937
a=7.5013(4)Å b=9.0509(5)Å c=9.3452(5)Å
α=75.253(2)° β=80.985(2)° γ=72.047(2)°
2,6-Dibromo-4-formylphenyl 3-phenylprop-2-enoate
C16H10Br2O3
Acta Crystallographica Section E (2012) 68, 10 o2873
a=8.0846(3)Å b=9.0149(4)Å c=11.8995(5)Å
α=77.429(2)° β=73.918(2)° γ=70.236(2)°
14-Ethoxy-4,6,9-trimethyl-8,12-dioxa-4,6- diazatetracyclo[8.8.0.0^2,7^.0^13,18^]octadeca- 2(7),13,15,17-tetraene-3,5,11-trione
C19H20N2O6
Acta Crystallographica Section E (2013) 69, 2 o272
a=9.3526(3)Å b=17.9559(5)Å c=10.9158(3)Å
α=90.00° β=101.3460(10)° γ=90.00°
(6b<i>S</i>*,14<i>R</i>*,14a<i>R</i>*)-Methyl 14-(4-methylphenyl)-7-oxo-6b,6c,7,12b,14,14a-hexahydro-1<i>H</i>- pyrano[3,2-<i>c</i>:5,4-<i>c</i>']dichromene-14a-carboxylate
C28H22O6
Acta Crystallographica Section E (2013) 69, 2 o267-o268
a=9.526(5)Å b=10.711(5)Å c=21.975(5)Å
α=90.0° β=97.397(5)° γ=90.0°
Methyl 6-ethoxy-3-phenyl-3a,4-dihydro-3<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-3a- carboxylate
C20H19NO5
Acta Crystallographica Section E (2013) 69, 2 o180
a=12.9342(6)Å b=7.5591(2)Å c=18.7138(8)Å
α=90.00° β=105.440(2)° γ=90.00°
3-(2-Methylphenyl)-3a,4-dihydro-3<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-3a- carbonitrile
C18H14N2O2
Acta Crystallographica Section E (2013) 69, 2 o181
a=19.326(3)Å b=10.7866(17)Å c=6.9072(11)Å
α=90.00° β=90.00° γ=90.00°
8-Bromo-3-phenyl-3a,4-dihydro-3<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-3a-carbonitrile
C17H11BrN2O2
Acta Crystallographica Section E (2013) 69, 2 o312
a=15.1034(8)Å b=6.0676(3)Å c=16.0865(10)Å
α=90.00° β=99.953(2)° γ=90.00°
Diethyl [(2-chloroanilino)(1,3-diphenyl-1<i>H</i>-pyrazol-4-yl)methyl]phosphonate
C26H27ClN3O3P
Acta Crystallographica Section E (2013) 69, 2 o182
a=11.2379(3)Å b=23.7075(6)Å c=9.4570(2)Å
α=90.00° β=90.8090(10)° γ=90.00°
Ethyl (2<i>E</i>,4<i>E</i>)-5-(3-bromophenylsulfonyl)penta-2,4-dienoate
C13H13BrO4S
Acta Crystallographica Section E (2013) 69, 4 o488
a=27.883(5)Å b=6.001(5)Å c=17.256(5)Å
α=90.00° β=94.020(5)° γ=90.00°
3-Methyl-2-vinylpyridinium phosphate
C8H10N,H2O4P
Acta Crystallographica Section E (2013) 69, 4 o487
a=7.7089(6)Å b=16.3668(13)Å c=8.0649(6)Å
α=90.00° β=109.689(4)° γ=90.00°
Diethyl 2,6-dimethyl-4-[4-(3-phenylacryloyloxy)phenyl]-1,4-dihydropyridine-3,5-dicarboxylate hemihydrate
C28H29NO6,0.5(H2O)
Acta Crystallographica Section E (2013) 69, 3 o389
a=25.4905(11)Å b=8.6166(4)Å c=23.2902(10)Å
α=90.00° β=92.235(2)° γ=90.00°
14-Methoxy-4,6-dimethyl-9-phenyl-8,12-dioxa-4,6-diazatetracyclo[8.8.0.0^2,7^.0^13,18^]octadeca-2(7),13,15,17-tetraene-3,5,11-trione
C23H20N2O6
Acta Crystallographica Section E (2013) 69, 8 o1199-o1200
a=9.2283(7)Å b=14.0584(10)Å c=16.4457(13)Å
α=94.869(2)° β=102.547(2)° γ=105.270(2)°
Methyl 1-phenyl-3-<i>p</i>-tolyl-1,9b-dihydro-3<i>H</i>-chromeno[4,3-<i>c</i>]isoxazole-3a(4<i>H</i>)-carboxylate
C25H23NO4
Acta Crystallographica Section E (2014) 70, 3 o281-o282
a=14.0674(7)Å b=7.8105(4)Å c=19.7680(9)Å
α=90.00° β=110.456(3)° γ=90.00°
(<i>E</i>)-(3-Ethyl-1-methyl-2,6-diphenylpiperidin-4-ylidene)amino phenyl carbonate
C27H28N2O3
Acta Crystallographica Section E (2014) 70, 10 199-202
a=9.3844(5)Å b=17.8121(8)Å c=14.4077(7)Å
α=90° β=107.216(2)° γ=90°
(<i>E</i>)-(3-Isopropyl-1-methyl-2,6-diphenylpiperidin-4-ylidene)amino phenyl carbonate
C28H30N2O3
Acta Crystallographica Section E (2014) 70, 10 199-202
a=10.3511(5)Å b=23.9398(10)Å c=10.0587(4)Å
α=90.00° β=94.997(2)° γ=90.00°